• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Carbohydrate quality rather than quantity affects risk of colorectal cancer

byAlex Chan
March 14, 2024
in Chronic Disease, Gastroenterology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a large prospective cohort, consumption of higher quality carbohydrates was associated with a decreased risk of colorectal cancer compared to lower quality carbohydrate diets.

2. Lower carbohydrate quantity consumption was not associated with significant correlations in colorectal cancer risk or outcomes.

Evidence Rating: 1 (Excellent)

Colorectal cancer (CRC) confers a significant healthcare burden worldwide, and it has been well documented that individual CRC risk can be mediated through diet. In prior literature, both the quantity and quality of carbohydrate consumption has been postulated as potential mediators of CRC risk and outcomes, although this has not been well characterized. To further characterize this link, patients from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, a large randomized clinical trial between 1993 and 2001, were followed over a mean follow-up of 8.8 years. They had both the quality and quantity of their carbohydrate consumption tracked, as measured by the carbohydrate quality index (CQI), and low-carbohydrate diet score (LCDs), respectively. CQI was calculated via a validated tool that assessed factors such as glycemic index, whole grain to total grain ratio, solid carbohydrate to total carbohydrate ratio, and dietary fiber. It was found that individuals in the highest quartiles of CQI had significant lower CRC incidence (HR 0.80 95% CI 0.67–0.96) and mortality (Q4 vs Q1: HR 0.61, 95% CI 0.44–0.86) when compared to those in the lowest quartiles, specifically for the distal colon and rectum. Interestingly, no associations were found between LCDs and CRC incidence or mortality in any CRC types. Study findings suggest that quality of carbohydrate intake, rather than quantity, has the effect on CRC incidence as well as mortality risk. With further research, practitioners and dietitians alike may utilize study findings to help counsel patients on their dietary choices to further mitigate CRC risk. 

Click to read the study in BMC Medicine

Image: PD

RELATED REPORTS

2 Minute Medicine Rewind June 23, 2025

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: colon cancerdietGastroenterologynutritiononcology
Previous Post

#VisualAbstract: Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma

Next Post

Atypical deglutition associated with obstructive sleep apnea in children

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind June 23, 2025

June 23, 2025
#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer
StudyGraphics

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

June 13, 2025
Lessons from real-world implementation of lung cancer screening
AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025
Elective colectomy associated with improved survival in ulcerative colitis
Chronic Disease

Rectoscopy alone may be sufficient to evaluate for remission of ulcerative colitis

June 9, 2025
Next Post
Parents with poor sleep quality report sleep problems in kids

Atypical deglutition associated with obstructive sleep apnea in children

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Early fixation of extremity fractures may be appropriate for patients with traumatic brain injury

Novel coronavirus identified from patients with pneumonia in Wuhan, China

2 Minute Medicine Rewind March 18, 2024

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
  • Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • 2 Minute Medicine Rewind June 23, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.